English | Español

Eli Lilly And Company
Ruth de Jauregui | Dec 4, 2016

Potential Alzheimer's drug fails to produce significant results
Ruth de Jauregui | Dec 4, 2016

Bridging the gap between patients, researchers
Robert Hadley | Dec 4, 2016

Patient advocacy, collaboration discussed at Brussels EFPIA meeting
Amanda Rupp | Oct 16, 2016

Health experts recommend adjusting expectations related to Alzheimer’s treatment goal
Amanda Rupp | Sep 18, 2016

Alzheimer’s Readiness Award granted to Boston mayor, local chapter of Alzheimer’s Association
Amanda Rupp | Aug 19, 2016

Lilly announces new promotions, retiree
Amanda Rupp | Jul 30, 2016

Potential connection found between Alzheimer’s progression, tau pathology
Amanda Rupp | Jul 7, 2016

Jardiance limits kidney disease risk for type 2 diabetes patients with cardiovascular disease

Trending
+ Marketing
Patient Daily | Sep 17, 2025

Patients Come First spokesperson: Drug ads 'are putting lives at risk by encouraging people to abandon essential treatments'
+ Regulatory
Patient Daily | Sep 17, 2025

PhRMA’s Senior Director on 340B: 'State and federal investigations have shown 340B is often exploited for profit'
+ Pharmaceuticals
Patient Daily | Sep 23, 2025

Wall Street Journal editorial board alleges hospitals misuse 340B program
Patient Daily | Sep 19, 2025

ENT specialist on ongoing chronic sinus cases: ‘Some of it could be incomplete surgery’